New York State Common Retirement Fund Galera Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$7.04 - $10.49 $528 - $786	-75 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$6.08 - $10.44 $12,901 - $22,153	-2,122 Reduced 96.59%	75 $1,000
Q1 2021 May 11, 2021	SELL	$8.35 - $12.39 $55,135 - $81,811	-6,603 Reduced 75.03%	2,197 $19,000
Q4 2020 Feb 08, 2021	BUY	$8.02 - $12.81 $64,160 - $102,480	8,000 Added 1000.0%	8,800 $90,000
Q1 2020 May 06, 2020	BUY	$5.89 - $17.67 $4,712 - $14,136	800 New	800 $8,000

10.7M

10.3K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $3.76M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.